Trials / Completed
CompletedNCT04992026
The Efficacy and Safety of Prostatectomy for Castration-Naive Oligometastatic Prostate Cancer
A Randomized, Controlled, Multi-Center Clinical Trial to Evaluate the Efficacy and Safety of Prostatectomy for Castration-Naive Oligometastatic Prostate Cancer
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 130 (actual)
- Sponsor
- The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School · Academic / Other
- Sex
- Male
- Age
- 40 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
This randomized, controlled, multi-center clinical trial aims to evaluate the efficacy and safety of prostatectomy for castration-Naive oligometastatic prostate cancer
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | robot assisted laparoscopic prostatectomy + enlarged pelvic lymph node dissection | Robot assisted laparoscopic prostatectomy + enlarged pelvic lymph node dissection will be performed. |
| DRUG | 1.Abiraterone Acetate Tablets | 1000mg(4 tablets, 250mg per tablet) daily for 6 cycles |
| DRUG | Prednisone Acetate Tablets | 5 mg oral low dose prednisone taken along with Abiraterone Acetate Tablets |
| DRUG | Luteinizing Hormone-Releasing Hormone Analog | Hypodermic injection of Luteinizing Hormone-Releasing Hormone Analog every 4 weeks including goserelin, leuprolide, triptorelin ect. |
Timeline
- Start date
- 2021-01-01
- Primary completion
- 2024-12-01
- Completion
- 2024-12-02
- First posted
- 2021-08-05
- Last updated
- 2024-12-05
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT04992026. Inclusion in this directory is not an endorsement.